M. Stevenson

Age- and sex-specific genomic profiles in non-small cell lung cancer.

J. Nevins, A. Potti, C. Acharya, 2010, JAMA.

Characterizing the Clinical Relevance of an Embryonic Stem Cell Phenotype in Lung Adenocarcinoma

A. Potti, C. Acharya, K. Walters, 2009, Clinical Cancer Research.

A Pathway-Based Approach to Identify Molecular Biomarkers in Cancer

A. Potti, M. Stevenson, 2012, Annals of Surgical Oncology.

Tumor Acquisition for Biomarker Research in Lung Cancer

G. Ginsburg, M. Wahidi, W. Barry, 2014, Cancer investigation.

A Phase 2 Clinical Trial of Combination Nivolumab, Ipilimumab, and Paclitaxel in Patients With Untreated Metastatic NSCLC: The OPTIMAL Trial

M. Stevenson, T. Stinchcombe, N. Ready, 2022, JTO clinical and research reports.

Occult primary, version 3.2014; Featured updates to the NCCN guidelines

D. Ettinger, A. Rashid, D. Gierada, 2014 .

Occult primary, version 3.2014.

D. Ettinger, A. Rashid, D. Gierada, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

Age-specific differences in oncogenic pathway dysregulation and anthracycline sensitivity in patients with acute myeloid leukemia.

K. Metzeler, S. Bohlander, C. Buske, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Characterizing the developmental pathways TTF-1, NKX2–8, and PAX9 in lung cancer

H. Dressman, J. Nevins, Sayan Mukherjee, 2009, Proceedings of the National Academy of Sciences.

Development of a virtual multidisciplinary lung cancer tumor board in a community setting.

M. Stevenson, L. Sutton, Tonia Irwin, 2013, Journal of oncology practice.

Characterizing the Clinical Relevance of an Embryonic Stem Cell Phenotype in Lung Adenocarcinoma

A. Potti, C. Acharya, K. Walters, 2009, Clinical Cancer Research.